| Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro. | |
| | |
MedLine Citation:
|
PMID: 2065856 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Five low doses (40 mg.kg-1.day-1) of streptozotocin were given to CD-1 mice to induce "immune" diabetes with insulitis. T-splenocytes (L3T4+ and Lyt2+) from streptozotocin-treated mice were previously reported to display in vitro an increased binding for Beta cells, preceding the onset of hyperglycaemia and of insulitis. Since heparin inhibits lymphocyte traffic, displays anti-adhesive properties, and attenuates some cell-mediated immune diseases, we have investigated the effects of heparin and N-desulphated heparin: 1) in vivo on low-dose streptozotocin-induced diabetes and insulitis, and 2) in vitro on the increased binding of T-splenocytes from streptozotocin-treated mice to rat insulinoma (RINm5F) cells. Daily subcutaneous low doses (5 micrograms or 10 micrograms) of heparin induced a delay in onset and a reduction of the severity of hyperglycaemia and insulitis (p less than 0.01), and reduced the incidence of diabetes (p less than 0.01). Similar effects were obtained with 5 micrograms daily doses of N-desulphated heparin devoid of anticoagulant activity. In contrast, lower (1 microgram) or higher (200 micrograms) doses of heparin were ineffective. Heparin (10 micrograms) did not modify the "toxic" diabetes induced by a single high dose (200 mg/kg) of streptozotocin. On the other hand, heparin dose-dependently (0.1 microgram/ml to 500.0 micrograms/ml) inhibited the increased binding of splenocytes from streptozotocin-injected mice to RIN cells as compared to splenocytes from control mice. This in vitro anti-adhesive effect was detected when either splenocytes or RIN cells were pretreated with heparin before their co-incubation, and was also obtained with N-desulphated heparin.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
P Saï; S Pogu; M Ouary |
Related Documents
:
|
10967576 - Successful large volume leukapheresis on a small infant allogeneic donor. 15909856 - Rational use of anti-snake venom (asv): trial of various regimens in hemotoxic snake en... 7605876 - Effect of repeated aprosulate and enoxaparin administration on tissue factor pathway in... 10584996 - Comparison of different routes of administration of nadroparin in hemodialysis. 16599876 - Management of status epilepticus. 11704566 - Adenosine modulates mg(2+) uptake in distal convoluted tubule cells via a(1) and a(2) p... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Diabetologia Volume: 34 ISSN: 0012-186X ISO Abbreviation: Diabetologia Publication Date: 1991 Apr |
Date Detail:
|
Created Date: 1991-08-13 Completed Date: 1991-08-13 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0006777 Medline TA: Diabetologia Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 212-7 Citation Subset: IM |
Affiliation:
|
Laboratoire d'Immunologie du Diabète, Faculté de Médecine, Nantes, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Glucose / metabolism Cell Adhesion / drug effects Cell Line Cells, Cultured Diabetes Mellitus, Experimental / drug therapy, immunology*, pathology Heparin / pharmacology*, therapeutic use Islets of Langerhans / drug effects, immunology*, pathology Male Mice Mice, Inbred Strains Spleen / immunology T-Lymphocytes / drug effects, immunology* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose ...
Next Document: Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin t...